​The focus of the Legacy Project will be the communities most impacted by the HIV epidemic in the United States: African Americans and Latinos. The Legacy Project will work collaboratively with the all DAIDS-funded HIV clinical trials networks: the AIDS Clinical Trials Group; the HIV Prevention Trials Network; the International Maternal Pediatric Adolescent AIDS Clinical Trials Group; the International Network for Strategic Initiatives in Global HIV Trials; and the Microbicide Trials Network, in addition to collaborating with the HVTN’s ongoing Legacy Project.

The Reverend Edwin Sanders, Chair of the Legacy Project’s Advisory Group, stated that this “is a tremendous opportunity to expand the innovative work of the HVTN’s Legacy Project across the spectrum of HIV clinical prevention and treatment research” and looks forward to working with the Legacy Project.

The Legacy Project focus areas are those activities that Legacy has direct impact upon. Those areas are:

• Primary Research
• Pilot Projects
• Cultural Competence and Responsiveness: Assessment & Program Development
• Relationship and Partnership Development, and
• Administrative Operations and Sustainability.

The Legacy Project will focus on three key objectives in the design and implementation of its projects and activities:

• Enhancing cultural competency and responsiveness within the DAIDS-funded HIV clinical trials networks and building relationships of trust with African-American and Latino communities within the U.S. to enhance participation of African-Americans, Latinos, and Latinas in DAIDS-funded HIV clinical trials.
• Fostering the continuum and critical linkages from testing, to referral to and entry into care, and an awareness of the opportunities to participate in clinical research, and
• Facilitating the referral of people who test HIV-negative to local HIV prevention programs and an awareness of opportunities to participate in HIV prevention trials.